Irish medtech firm Neuromod Devices sets up US subsidiary

The company, which specialises in treatment of tinnitus, announces three US-based executive appointments as it seeks FDA approval for its product

Ross O’Neill, chief executive of Neuromod Devices, said the company aims to meet the needs of the estimated 50 million people in the US with tinnitus. Picture: Fergal Phillips